Sort   by:  
 Page size 
UnknownSequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer.
Not available
S-EPMC3236650 | biostudies-literature
UnknownIncorporating Digital Tools to Improve Clinical Trial Infrastructure: A White Paper From the Digital Engagement Committee of SWOG.
Not available
S-EPMC6668704 | biostudies-literature
UnknownGenomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.
Not available
S-EPMC4334774 | biostudies-literature
UnknownCirculating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.
Not available
S-EPMC4209100 | biostudies-literature
UnknownImpact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial.
Not available
S-EPMC3731983 | biostudies-literature
UnknownSWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.
Not available
S-EPMC4268253 | biostudies-literature
Sort   by:  
 Page size